Menu

Blog

Page 10992

Jul 11, 2016

The Freaky Artificial Muscles on this Human Skeleton Are the Future of Robotics

Posted by in category: robotics/AI

Using pneumatic pistons and servos to power robots makes them fast and strong, but also bulky and extremely heavy. No one is going to mistake ATLAS for a real human being. To eventually create humanoid-looking robots like the Terminator we need to mechanically replicate every part of the human anatomy—starting with the muscles.

Researchers at the Suzumori Endo Robotics Laboratory at the Tokyo Institute of Technology started with an artificial human skeleton that was then covered in bundles of multifilament artificial muscles. Like real human muscles, the multifilament bundles contract and expand when an electrical current is applied, and by controlling different groups of these muscles at different times, the skeleton’s arms, legs, and head can all be made to move similar to how a real human can.

Continue reading “The Freaky Artificial Muscles on this Human Skeleton Are the Future of Robotics” »

Jul 11, 2016

3 Reasons You Are Living in the Matrix / How to Make a Red Pill

Posted by in categories: complex systems, disruptive technology, education, governance, government, philosophy, physics, policy, rants, science, scientific freedom

Appearances have always played a much more important part than reality in history, where the unreal is always of greater moment than the real.“
–Gustav LeBon, The Crowd (1895)

I’ve gotten no substantive response to my last post on vaccine safety– neither in the comments, nor the TruthSift diagram, nor anywhere else, nor have the papers I submitted to two medical journals… but I have gotten emails telling me I’m delusional and suggesting I seek psychiatric attention. And this of course is integral to the explanation of how such delusions as vaccine safety persist so widely when it is so demonstrably a delusion: the majority who believe the majority must be right because its the majority are emotionally unwilling to confront the evidence. They assume the experts have done that, and they rely on the experts. But the experts assume other experts have been there. Ask your Pediatrician if he’s personally read Bishop et al and formulated an opinion on vaccine aluminum. Neither has the National Academy, except perhaps their members have and decided, perhaps tacitly, not to review the subject. Their decision not to review the animal literature was not tacit, they said they explicitly decided to omit it, although elsewhere they say they couldn’t find human evidence that addressed the issues. So everybody is trusting somebody else, and nobody has picked up the ball. And can you blame them? Because when I pick up the ball, what I receive in return is hate mail and people’s scorn. The emotional response cuts off any possible inspection of the logic.

On most questions where a majority with authority is facing a minority of dissenters or skeptics, the majority is delusional.
In other words, you are living in the matrix; much of what you and people believe is fundamentlaly wrong.

Reason 1, as above, is that the majority forms its view by circular reasoning, and rejects any attempt at logical discussion without considering it seriously, so it is prone to delusion.
Once the crowd concluded vaccines are safe and effective, for example, the question of whether the aluminum is damaging can apparently no longer be raised (even as more gets added to vaccines). And when I or others try to raise it, we are scorned and hated, and ineffectual in changing the opinion supported by circular reasoning. When new research papers appear that call it into question, they are ignored, neither cited in the safety surveys nor influencing medical practice in any way. This paragraph is all simple reporting of what has repeatedly happened.

Continue reading “3 Reasons You Are Living in the Matrix / How to Make a Red Pill” »

Jul 11, 2016

Nanotech ‘tattoo’ can map emotions and monitor muscle activity

Posted by in category: nanotechnology

Um nova “tatuagem eletrônica”, desenvolvido pela Universidade de Tel Aviv, que pode medir a atividade de pesquisadores células musculares e nervosas está pronta para revolucionar a medicina, reabilitação, e até mesmo de negócios e pesquisa de marketing.

Read more

Jul 11, 2016

Pomegranate finally reveals its powerful anti-aging secret

Posted by in categories: biotech/medical, health, life extension

Are pomegranates really the superfood we’ve been led to believe will counteract the aging process? Up to now, scientific proof has been fairly weak. And some controversial marketing tactics have led to skepticism as well. A team of scientists from EPFL and the company Amazentis wanted to explore the issue by taking a closer look at the secrets of this plump pink fruit. They discovered that a molecule in pomegranates, transformed by microbes in the gut, enables muscle cells to protect themselves against one of the major causes of aging. In nematodes and rodents, the effect is nothing short of amazing. Human clinical trials are currently underway, but these initial findings have already been published in the journal Nature Medicine.

As we age, our cells increasingly struggle to recycle their powerhouses. Called mitochondria, these inner compartments are no longer able to carry out their vital function, thus accumulate in the cell. This degradation affects the health of many tissues, including muscles, which gradually weaken over the years. A buildup of dysfunctional mitochondria is also suspected of playing a role in other diseases of aging, such as Parkinson’s disease.

One molecule plays David against the Goliath of aging

Continue reading “Pomegranate finally reveals its powerful anti-aging secret” »

Jul 11, 2016

Meet the First Artificial Animal

Posted by in categories: 3D printing, bioengineering, genetics, robotics/AI

Scientists genetically engineered and 3D-printed a biohybrid being, opening the door further for lifelike robots and artificial intelligence.

By Lisa Calhoun

Read more

Jul 11, 2016

This startup wants to replace the silicon in your smartphone with diamonds

Posted by in categories: 3D printing, biotech/medical, mobile phones

Synthetic diamonds and the manufacturing of diamonds in mass quantity (including 3D Printing) is going to explode over the next few years with QC, Medical devices and technologies, smartphones, etc. Again, I hope Intel, Nvidia, HP, Xerox, etc. are listening.


Chicago-based startup Akhan Semiconducton wants to replace the silicon found in most modern-day electronics with diamonds derived from methane gas.

Continue reading “This startup wants to replace the silicon in your smartphone with diamonds” »

Jul 11, 2016

Food Ink. the first 3D printing restaurant to serve nine-course 3D printed dinner in London

Posted by in categories: 3D printing, food

Want a gourmet cook; 3D printing is giving that to you.


Dutch 3D printed food innovators byFlow are ready to take their Food Ink pop-up restaurant to London, where they will be setting up a gastropub to serve nine-course 3D printed dinners from 25 to 27 July.

Continue reading “Food Ink. the first 3D printing restaurant to serve nine-course 3D printed dinner in London” »

Jul 11, 2016

Engineered human colon model could aid in cancer research

Posted by in category: biotech/medical

Cornell researchers have helped develop a recellularized human colon model that could be used to track the pathogenesis of colon cancer and possibly gain insight into its spread to other organs.

Read more

Jul 11, 2016

FDA study using genetically engineered cells to treat cancer kills three people

Posted by in categories: bioengineering, biotech/medical, genetics, neuroscience

(NaturalNews) Earlier this month, Juno Therapeutics, a pioneer in the field of treating cancer using genetically engineered cells, had to halt the development of its lead treatment after the death of three leukemia patients enrolled in the study.

The Seattle-based biotech company reported that the deaths of all three patients, who were in their 20s, were linked to swelling in the brain. The swelling occurred after the company added a second chemotherapy drug to the treatment procedure.

The news of the patient deaths is a big blow for the biotech startup that is developing a new experimental therapy known as chimeric antigen receptor T-cell (or CART) immunotherapy. The setback will likely delay the company’s aim of introducing it to the market by 2017, Juno executives said in a conference.

Continue reading “FDA study using genetically engineered cells to treat cancer kills three people” »

Jul 11, 2016

Research suggests common blood cancer could be prevented before it develops

Posted by in category: biotech/medical

They discovered that changes in the bone marrow needed for the cancer to grow have already taken hold in the preceding condition, raising the possibility that early medical intervention could prevent this incurable type of cancer from taking root.

The research, which was funded by the blood cancer charity Bloodwise, is published in the journal Leukemia.

Myeloma affects the plasma cells, a type of white blood cell that originates in the bone marrow. Diagnosed in over 4,000 people a year in the UK, fewer than half of patients survive for longer than five years after diagnosis. Symptoms often include debilitating and painful bone damage, anemia and nausea.

Read more